Related Experiment Video
Updated: Oct 26, 2025
07:47
Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
15.8K
[Progress on economic evaluation of pneumococcal vaccine]
Summary
Pneumococcal vaccines like PCV-10, PCV-13, and PPSV-23 are often cost-effective for individuals over 50. China needs local data for accurate economic evaluations of pneumococcal vaccination programs.
Area of Science:
- Public Health
- Health Economics
- Vaccinology
Background:
- Pneumococcal disease poses a significant public health burden globally.
- Economic evaluations are crucial for informing vaccination policy decisions.
- Pneumococcal conjugate vaccines (PCV-10, PCV-13) and pneumococcal polysaccharide vaccine (PPSV-23) are key interventions.
Purpose of the Study:
- To review and synthesize the economic evaluations of PCV-10, PCV-13, and PPSV-23.
- To provide evidence-based references for decision-making and research in China.
- To identify gaps in current economic evaluations relevant to the Chinese context.
Main Methods:
- Systematic literature review of economic evaluations of pneumococcal vaccines.
- Extraction of data on study design, modeling techniques, costs, and outcomes (QALY, LYG).
- Analysis of cost-effectiveness findings, particularly for populations over 50 years.
Main Results:
- Seventeen studies were included in the review.
- Markov models were the predominant methodology (14 studies).
- A majority of studies (69.2%) involving individuals over 50 found pneumococcal vaccination to be cost-effective.
Conclusions:
- Pneumococcal vaccination demonstrates cost-effectiveness in various populations, particularly older adults.
- China requires region-specific epidemiological data and vaccine effectiveness information.
- Conducting localized economic evaluations is essential for optimizing pneumococcal vaccination strategies in China.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
534
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
534
01:28Pneumonia IV: Management
524
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
524
01:30Pneumonia V: Nursing management and Prevention
2.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
01:30Pneumonia I: Introduction
427
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
427
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
208
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
208
01:28Antimicrobial Effectiveness
652
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
652